TEVA-CLINDAMYCIN dose modification may not be necessary in patients with renal disease. TEVA-CLINDAMYCIN dosage modification is not necessary in
patients with a normal renal function. This treatment should be administered Clindamycin phosphate IV or clindamycin hydrochloride orally in a dose of 600-
In the setting of renal dysfunction, a single dose Ceftriaxone, clindamycin, and moxifloxacin do not require dose adjustment in renal dysfunction (19).
Dosage in renal impairment. Clindamycin dosage modification is not necessary in patients with renal insufficiency. The dose and method of
Clindamycin. Clindamycin. Usual Dosing (Adults). (IV) 300 to 900 mg q6-8h. (Oral): mg q6h. Renal Dosing. dialysis. No adjustments
TEVA-CLINDAMYCIN dose modification may not be necessary in patients with renal disease. TEVA-CLINDAMYCIN dosage modification is not necessary in
clindamycin Dose Adjustment in Renal Impairment. February 2024: shortage of all forms of parenteral clindamycin; Use is reserved to
clindamycin Dose Adjustment in Renal Impairment. February 2024: shortage of all forms of parenteral clindamycin; Use is reserved to
RIVA-CLINDAMYCIN dose modification may not be necessary in patients with renal disease. RIVA-. CLINDAMYCIN dosage modification is not necessary
Comments